Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAFV600E mutation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Brain Tumor Pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10014-015-0231-7PMID 26404554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

  2015cited by this paper
• Intratumoral Heterogeneity of Genomic Imbalance in a Case of Epithelioid Glioblastoma with BRAF V600E Mutation

  2014cited by this paper
• Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation

  2014influential reference
• Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

  2013cited by this paper
• Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation

  2013cited by this paper
• The Definition of Primary and Secondary Glioblastoma

  2012cited by this paper
• Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

  2011cited by this paper
• Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

  2010cited by this paper
• IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas

  2009cited by this paper
• EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW‐GRADE GLIOMAS

  2008cited by this paper
• Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

  2008cited by this paper
• BRAFE600 in benign and malignant human tumours

  2008cited by this paper
• Characterization of Glioblastomas in Young Adults

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Characterization of Glioblastomas in Young Adults

  2006cited by this paper
• Genetic Pathways to Glioblastoma

  2004cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.

  2001cited by this paper
• Rhabdoid glioblastoma.

  2001cited by this paper
• Loss of Heterozygosity on Chromosome 19 in Secondary Glioblastomas

  2000cited by this paper
• PTEN (MMAC1) Mutations Are Frequent in Primary Glioblastomas (de novo) but not in Secondary Glioblastomas

  1998cited by this paper
• The Lipid‐Rich Epithelioid Glioblastorna

  1991cited by this paper

• Impact of GAP-43, Cx43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas

  2023cites this paper
• Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?

  2023cites this paper
• Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report

  2022cites this paper
• Analysis of Histomorphological/molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidate for Immune Checkpoint Blockade

  2021cites this paper
• Malignant transformation of pleomorphic xanthoastrocytoma in pregnant patient: Clinical case and ethical dilemma

  2021influential citation
• Future generation of combined multimodal approach to treat brain glioblastoma multiforme and potential impact on micturition control

  2021cites this paper
• Novel approaches to combat chemoresistance against glioblastomas

  2020cites this paper
• Confirming diagnosis and effective treatment for rare epithelioid glioblastoma variant: an integrated survival analysis of the literature.

  2019cites this paper
• Nucleolar and spindle‐associated protein 1 is a tumor grade correlated prognosis marker for glioma patients

  2018cites this paper
• Intraventricular Epithelioid Glioblastoma: A Case Report.

  2018cites this paper
• Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation

  2018cites this paper
• Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma

  2018cites this paper
• Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer

  2017cites this paper
• 成人の側頭葉に発生したBRAF V600Eの変異とanaplastic featureを伴ったpilocytic astrocytomaの1例

  2017cites this paper
• Risk Factors for Malignant Transformation of Low-Grade Glioma.

  2017cites this paper
• Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations

  2017cites this paper